In this contemporary report of irAEs associated with high dose IL-2 treatment, the following observations have been made: [1] Overall, patients developing IL-2 related irAEs have significantly improved response (CR + PR) and tumor control (CR + PR + SD) compared to those who did not develop irAEs (Table 4). This evidence concerns the gene IL2 and neoplasm.